Peptide Purity and HPLC Testing Explained for Researchers

When Signal Labs lists a peptide at greater than or equal to 98% purity as verified by HPLC, what does that actually mean? Understanding peptide purity — how it is measured, what the impurities are, and why it matters for research — is fundamental to evaluating research compounds and interpreting experimental results. This guide explains the essentials.

What is HPLC?

HPLC stands for High-Performance Liquid Chromatography. It is the gold-standard analytical technique for measuring peptide purity in the research and pharmaceutical industries. The technique works by separating components of a mixture based on their differential interaction with a stationary phase (typically a reverse-phase C18 column) and a mobile phase (typically an aqueous/organic solvent gradient).

In a typical reverse-phase HPLC analysis of a peptide sample, the peptide and any impurities are injected onto the column and eluted over a gradient from aqueous (hydrophilic) to organic (hydrophobic) solvent. Different compounds elute at different times (the "retention time") based on their hydrophobicity. A UV detector at 214 nm detects the peptide bonds in all peptide-containing peaks, producing a chromatogram showing a peak for each component.

What Does 98% Purity Mean?

Peptide purity by HPLC is expressed as the percentage of the total UV absorbance area represented by the main peptide peak.

98% purity means that the main peak (the desired peptide) represents 98% of the total integrated peak area in the HPLC chromatogram. The remaining 2% represents impurities — which may include deletion sequences, truncated sequences, oxidised or deamidated variants, residual synthesis reagents, or salts.

This is a measurement of chemical purity — it does not directly measure biological activity. A 98% pure peptide is expected to have high biological activity in research assays, but purity alone does not guarantee that the correct peptide sequence was synthesised. This is why mass spectrometry (MS) confirmation of molecular mass — which confirms the correct sequence was made — is an important complement to HPLC purity.

Common Peptide Impurities

Deletion sequences. During solid-phase peptide synthesis, incomplete coupling of amino acids generates truncated sequences missing one or more residues. A deletion sequence may have a similar retention time to the target peptide, making it difficult to separate by HPLC. Deletion sequences can have significantly different or absent biological activity.

Oxidised variants. Methionine-containing peptides (Semax, TB-500) and tryptophan-containing peptides (LL-37, Kisspeptin-10) can generate oxidised variants during synthesis or storage. Methionine sulphoxide (Met[O]) is a common oxidation product. These variants typically elute at slightly different retention times and are quantified in the HPLC purity calculation.

Deamidation products. Asparagine residues can deamidate to aspartate, producing a structural isomer with the same mass but different charge and chromatographic behaviour. CJC-1295 eliminates the deamidation site at position 8 by substituting Gln for Asn.

TFA salt. Many peptides are supplied as trifluoroacetate (TFA) salts from the standard HPLC purification process using TFA-containing mobile phases. TFA is not counted in the purity calculation but may be present and can affect biological assays at high concentrations. Some suppliers offer acetate or hydrochloride salt forms instead.

Residual solvents and reagents. Small quantities of synthesis solvents (DMF, NMP, DCM) or coupling reagents may remain. These are typically removed during final purification and lyophilisation.

Why Purity Matters for Research

Reproducibility. A 95% pure peptide and a 98% pure peptide of the same compound will behave differently in biological assays if the 5% impurity in the lower-purity sample has biological activity at the concentrations used. For dose-response studies, impurities can shift apparent EC50 values or mask true pharmacology.

Mechanistic interpretation. If a biological effect is observed and attributed to the target peptide, but the sample contains 5% of a related deletion sequence, the attribution may be incorrect. High purity reduces the likelihood that observed effects are caused by impurities.

Regulatory compliance. For any research that might eventually support regulatory submissions, purity records and certificates of analysis are essential documentation.

Certificate of Analysis: What to Look For

A complete peptide certificate of analysis should include:

Signal Labs provides certificates of analysis for all products. If you need a batch-specific CoA, contact support with your batch number.

Mass Spectrometry: The Complement to HPLC

HPLC purity tells you how much of the sample is the main peak — but it does not confirm what that main peak is. Mass spectrometry (MS or LC-MS) determines the molecular mass of the peptide, confirming that the synthesised sequence matches the expected molecular weight within a tight tolerance (typically ±1 Da for small peptides, ±0.1% for larger ones).

A complete analytical package of HPLC purity plus MS molecular weight confirmation provides high confidence in both purity and identity. This combination is what rigorous research peptide suppliers provide in their certificate of analysis documentation.

For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied.

What is lyophilisation? | Storage guide | Browse all peptides

HPLC Method Validation for Peptide Analysis

The HPLC method used for peptide purity analysis must be validated to ensure reliable results. Key validation parameters for peptide purity by reverse-phase HPLC:

Specificity: The method must separate the target peptide from all known impurities including deletion sequences, oxidised variants, and synthesis reagent residues. This is demonstrated by spiking reference standards of known impurities and confirming they are chromatographically resolved from the main peak.

Linearity: UV absorbance at 214nm must show linear response to peptide concentration across the expected range (typically 0.01-1 mg/mL). All peptide bonds absorb at 214nm (the peptide bond chromophore), making this wavelength universal for peptide detection regardless of sequence. For peptides containing aromatic residues (Trp, Tyr, Phe), 280nm detection provides additional sequence-specific information.

Precision: Repeatability (same analyst, same day) and intermediate precision (different days, possibly different analysts) should be characterised. For peptide purity analysis, repeatability CVs below 0.5% for retention time and below 1% for peak area are typically achievable on well-maintained HPLC systems.

Detection and quantification limits: The LOD and LOQ determine the minimum impurity level detectable. For a specification of greater than or equal to 98% purity, the method must reliably quantify impurities at 0.1-0.5% of the main peak area.

Mass Spectrometry Complement to HPLC

HPLC purity tells you how much of the sample is the main peak by UV absorbance area — it does not confirm what that peak is. Mass spectrometry (typically LC-MS or MALDI-TOF) confirms the molecular weight of the peptide, providing sequence identity confirmation.

For synthetic peptides, the expected molecular weight calculated from the amino acid sequence and modifications should match the observed mass within the instrument's mass accuracy (typically ±0.01% for high-resolution instruments). A peptide at 98% purity by HPLC but with incorrect mass by MS indicates that the wrong sequence was synthesised — the impurities are minor but the bulk material is not the intended compound.

Signal Labs provides HPLC purity data verified to greater than or equal to 98% for all research compounds. Mass spectrometry confirmation of molecular identity is available on request for specific batches. Contact support with your batch number for analytical documentation.

Frequently Asked Questions

What does "purity" mean for a glycoprotein like HCG versus a synthetic peptide?
For synthetic peptides, HPLC purity reflects the percentage of the chromatographic signal attributable to the intended molecular species — a straightforward chemical purity measurement. For glycoproteins like HCG, purity is more complex because the same protein backbone can carry multiple glycoforms (different carbohydrate structures) that produce multiple HPLC peaks from a single, pure protein species. HCG purity is typically expressed as biological activity (IU/mg) rather than HPLC purity — activity assays that measure receptor binding or functional response are more meaningful than chemical purity for glycoproteins where heterogeneity is inherent in the glycosylation.

What is the difference between HPLC purity and "pharmaceutical grade" purity?
HPLC purity measures chemical impurities detectable at 214nm — it does not measure biological contaminants (endotoxins, viruses, mycoplasma), sterility, or residual solvents below the HPLC detection limit. Pharmaceutical grade specifications additionally require: endotoxin testing (LAL assay), sterility testing (USP <71>), residual solvent analysis, and potentially bioassay confirmation of biological activity. Signal Labs research compounds are supplied at chemical purity greater than or equal to 98% by HPLC for laboratory research use; they are not pharmaceutical grade and are not suitable for clinical administration.

Browse all Signal Labs research peptides | Peptide storage guide | Reconstitution guide

Interpreting Your Certificate of Analysis

Every Signal Labs batch ships with a Certificate of Analysis (CoA) confirming purity by reverse-phase HPLC. Understanding how to read this document ensures you can verify the quality of your research compound before use.

Main peak area percentage: The purity figure (e.g., 98.7%) represents the main peak's area as a percentage of total integrated area across the chromatogram. This is calculated: purity (%) = (main peak area / sum of all peak areas) × 100. Impurity peaks appear as smaller peaks at different retention times.

Retention time: The time at which the peptide elutes from the column under the stated gradient conditions. This is characteristic of the compound's hydrophobicity and can serve as an identity check — if your in-house HPLC system reproduces a similar relative retention time, this supports identity. Absolute retention times vary between instruments and columns.

System suitability: A well-run HPLC method includes system suitability checks — typically a reference standard injected at the start of the analytical sequence confirming the column is performing within specification for peak width, tailing factor, and retention time precision before sample analysis begins.

For questions about specific batch CoA data, contact Signal Labs with your batch number.